Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024
Restricted cash	$ 121,688	$ 43,371
Deferred financing costs	$ 43,154	$ 28,306
Common shares, par value	$ 0.001	$ 0.001
Common shares, issued	141,664,937	140,208,028
Common shares, outstanding	141,664,937	140,208,028
Non-controlled, Non-affiliated Investments
Investments at amortized cost	$ 7,172,247	$ 7,079,994